Learn about the rights of Cystic Fibrosis Foundation donors.
Site Search
Showing 361 - 370 of 404 results
News
|
May 28, 2009
|
2 min read
News
|
Jan. 24, 2013
|
5 min read
News
|
Nov. 5, 2013
|
3 min read
News
|
Aug. 31, 2012
|
6 min read
News
|
Oct. 19, 2012
|
3 min read
The European Commission has approved the use of the CF therapy Kalydeco™ for people with the G551D mutation ages 6 and older in the European Union.
News
|
July 27, 2012
|
1 min read
News
|
Oct. 23, 2012
|
3 min read
News
|
Oct. 22, 2012
|
2 min read
The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
News
|
March 2, 2012
|
1 min read